Psoriatic Arthritis Treatment Market, by Drug Class (NSAIDs (Non-steroidal Anti-inflammatory Drugs), DMARD (Non-biologic Disease Modifying Anti-Rheumatic Drugs), Biologics, and Others {Others include Immunosuppressant, Enzyme Inhibitor, and Interleukin In

Psoriatic Arthritis Treatment Market, by Drug Class (NSAIDs (Non-steroidal Anti-inflammatory Drugs), DMARD (Non-biologic Disease Modifying Anti-Rheumatic Drugs), Biologics, and Others {Others include Immunosuppressant, Enzyme Inhibitor, and Interleukin Inhibitors}), by Disease Type (Asymmetric Psoriatic Arthritis, Symmetric Psoriatic Arthritis, Distal Interphalangeal Predominant (Dip) Psoriatic Arthritis, Psoriatic Spondylitis, and Psoriatic Arthritis Mutilans), by Drug Type (Prescriptions and Over-the-counter), by Route of Administration (Topical, Oral, and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Psoriatic arthritis is one of the types of inflammatory arthritis that occurs in some people suffering from psoriasis, a skin condition wherein red, scaly patches appear on the skin. Usually, psoriasis is followed by psoriatic arthritis, however, pain in joints may start even before any patches are visible on the skin of the patient. Some of the symptoms associated with psoriatic arthritis include pain, swelling, and stiffness in joints. Painful, swelling of fingers and toes can be observed in patients suffering from psoriatic arthritis. Some people suffer from spondylitis caused due to psoriatic arthritis. In spondylitis, inflammation of joints between vertebrae and spine occurs along with inflammation in joints between spine and pelvis. Some of the factors that increase the risk of psoriatic arthritis include age, genetics, and having psoriasis. Psoriatic arthritis is incurable, thus it is important to manage its symptoms using available therapeutic drugs related to psoriatic arthritis. This is expected to drive the growth of psoriatic arthritis market.

Market Dynamics

The increasing incidence of psoriasis and psoriatic arthritis, rising research and development activities for the development of novel therapeutics for the treatment of psoriatic arthritis, and increasing adoption of inorganic growth strategies such as acquisitions and collaborations by key players operating in the market, are the major factors that are expected to drive the growth of the global psoriatic arthritis treatment market over the forecast period.

For instance, according to a review article by Seminars in Arthritis and Rheumatism Journal published in August 2018, the global prevalence of psoriatic arthritis was estimated to be 133 every 100,000 people in 2018.

Key features of the study:

    LI> This report provides in-depth analysis of the global psoriatic arthritis treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global psoriatic arthritis treatment market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include AbbVie Inc., Otsuka Pharmaceutical Co., Ltd., Amgen Inc., Sanofi S.A., Johnson & Johnson Services, Inc., Novartis International AG, AstraZeneca, Bausch Health Companies Inc., Janssen Biotech, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Pfizer, Inc., UCB S.A., Sun Pharma Global FZE, AltruBio, Merck & Co Inc., and Celgene Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global psoriatic arthritis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global psoriatic arthritis treatment market
Detailed Segmentation:
    LI> Global Psoriatic Arthritis Treatment Market, By Drug Class:
  • NSAIDs (Non-steroidal Anti-inflammatory Drugs)
  • DMARD (Non-biologic Disease Modifying Anti-Rheumatic Drugs)
  • Biologics
  • Others (Others includes Immunosuppressant, Enzyme Inhibitor, and Interleukin Inhibitors)
  • Global Psoriatic Arthritis Treatment Market, By Disease Type:
  • Asymmetric Psoriatic Arthritis
  • Symmetric Psoriatic Arthritis
  • Distal Interphalangeal Predominant (Dip) Psoriatic Arthritis
  • Psoriatic Spondylitis
  • Psoriatic Arthritis Mutilans
  • Global Psoriatic Arthritis Treatment Market, By Drug Type:
  • Prescriptions
  • Over-the-counter
  • Global Psoriatic Arthritis Treatment Market, By Route of Administration:
  • Topical
  • Oral
  • Injectable
  • Global Psoriatic Arthritis Treatment Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Psoriatic Arthritis Treatment Market, By Region:
  • North America
  • By Drug Class
  • NSAIDs (Non-steroidal Anti-inflammatory Drugs)
  • DMARD (Non-biologic Disease Modifying Anti-Rheumatic Drugs)
  • Biologics
  • Others (Others includes Immunosuppressant, Enzyme Inhibitor and Interleukin Inhibitors)
  • By Disease Type
  • Asymmetric Psoriatic Arthritis
  • Symmetric Psoriatic Arthritis
  • Distal Interphalangeal Predominant (Dip) Psoriatic Arthritis
  • Psoriatic Spondylitis
  • Psoriatic Arthritis Mutilans
  • By Drug Type
  • Prescriptions
  • Over-the-counter
  • By Route of Administration
  • Topical
  • Oral
  • Injectable
  • By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Drug Class
  • NSAIDs (Non-steroidal Anti-inflammatory Drugs)
  • DMARD (Non-biologic Disease Modifying Anti-Rheumatic Drugs)
  • Biologics
  • Others (Others includes Immunosuppressant, Enzyme Inhibitor, and Interleukin Inhibitors)
  • By Disease Type
  • Asymmetric Psoriatic Arthritis
  • Symmetric Psoriatic Arthritis
  • Distal Interphalangeal Predominant (Dip) Psoriatic Arthritis
  • Psoriatic Spondylitis
  • Psoriatic Arthritis Mutilans
  • By Drug Type
  • Prescriptions
  • Over-the-counter
  • By Route of Administration
  • Topical
  • Oral
  • Injectable
  • By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Drug Class
  • NSAIDs (Non-steroidal Anti-inflammatory Drugs)
  • DMARD (Non-biologic Disease Modifying Anti-Rheumatic Drugs)
  • Biologics
  • Others (Others includes Immunosuppressant, Enzyme Inhibitor, and Interleukin Inhibitors)
  • By Disease Type
  • Asymmetric Psoriatic Arthritis
  • Symmetric Psoriatic Arthritis
  • Distal Interphalangeal Predominant (Dip) Psoriatic Arthritis
  • Psoriatic Spondylitis
  • Psoriatic Arthritis Mutilans
  • By Drug Type
  • Prescriptions
  • Over-the-counter
  • By Route of Administration
  • Topical
  • Oral
  • Injectable
  • By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Drug Class
  • NSAIDs (Non-steroidal Anti-inflammatory Drugs)
  • DMARD (Non-biologic Disease Modifying Anti-Rheumatic Drugs)
  • Biologics
  • Others (Others includes Immunosuppressant, Enzyme Inhibitor and Interleukin Inhibitors)
  • By Disease Type
  • Asymmetric Psoriatic Arthritis
  • Symmetric Psoriatic Arthritis
  • Distal Interphalangeal Predominant (Dip) Psoriatic Arthritis
  • Psoriatic Spondylitis
  • Psoriatic Arthritis Mutilans
  • By Drug Type
  • Prescriptions
  • Over-the-counter
  • By Route of Administration
  • Topical
  • Oral
  • Injectable
  • By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Drug Class
  • NSAIDs (Non-steroidal Anti-inflammatory Drugs)
  • DMARD (Non-biologic Disease Modifying Anti-Rheumatic Drugs)
  • Biologics
  • Others (Others includes Immunosuppressant, Enzyme Inhibitor and Interleukin Inhibitors)
  • By Disease Type
  • Asymmetric Psoriatic Arthritis
  • Symmetric Psoriatic Arthritis
  • Distal Interphalangeal Predominant (Dip) Psoriatic Arthritis
  • Psoriatic Spondylitis
  • Psoriatic Arthritis Mutilans
  • By Drug Type
  • Prescriptions
  • Over-the-counter
  • By Route of Administration
  • Topical
  • Oral
  • Injectable
  • By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Drug Class
  • NSAIDs (Non-steroidal Anti-inflammatory Drugs)
  • DMARD (Non-biologic Disease Modifying Anti-Rheumatic Drugs)
  • Biologics
  • Others (Others includes Immunosuppressant, Enzyme Inhibitor and Interleukin Inhibitors)
  • By Disease Type
  • Asymmetric Psoriatic Arthritis
  • Symmetric Psoriatic Arthritis
  • Distal Interphalangeal Predominant (Dip) Psoriatic Arthritis
  • Psoriatic Spondylitis
  • Psoriatic Arthritis Mutilans
  • By Drug Type
  • Prescriptions
  • Over-the-counter
  • By Route of Administration
  • Topical
  • Oral
  • Injectable
  • By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country/Region
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • AbbVie Inc.*
  • Company Overview
  • Material Portfolio
  • Financial Performance
  • Key Highlights
  • Market Strategies
  • Otsuka Pharmaceutical Co., Ltd.
  • Amgen Inc.
  • Sanofi S.A.
  • Johnson & Johnson Services, Inc.
  • Novartis International AG
  • AstraZeneca
  • Bausch Health Companies Inc.
  • Janssen Biotech, Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Pfizer, Inc.
  • UCB S.A.
  • Sun Pharma Global FZE
  • AltruBio
  • Merck & Co Inc.
  • Celgene Corporation
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Drug Class
Market Snippet, By Disease Type
Market Snippet, By Drug Type
Market Snippet, By Route of Administration
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Pipeline Analysis
o PEST Analysis
o Regulatory Scenario
o Market Trends
o Key Highlights
o Reimbursement Scenario
o Mergers & Acquisitions
4. Global Psoriatic Arthritis Treatment Market – Impact of Coronavirus (Covid-19) Pandemic
o Economic Impact
o Impact on Clinical Trials and Drug Development
o Government Initiatives
5. Global Psoriatic Arthritis Treatment Market, By Drug Class, 2017 – 2028, (US$ Mn)
o Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 – 2028
Segment Trends
o NSAIDs (Non-steroidal Anti-inflammatory Drugs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
o DMARD (Non-biologic Disease Modifying Anti-Rheumatic Drugs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
o Biologics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
o Others (Others includes Immunosuppressant, Enzyme Inhibitor, and Interleukin Inhibitors)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
6. Global Psoriatic Arthritis Treatment Market, By Disease Type, 2017 – 2028, (US$ Mn)
o Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 – 2028
Segment Trends
o Asymmetric Psoriatic Arthritis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
o Symmetric Psoriatic Arthritis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
o Distal Interphalangeal Predominant (Dip) Psoriatic Arthritis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
o Psoriatic Spondylitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
o Psoriatic Arthritis Mutilans
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
7. Global Psoriatic Arthritis Treatment Market, By Drug Type, 2017 – 2028, (US$ Mn)
o Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 – 2028
Segment Trends
o Prescriptions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
o Over-the-counter
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
8. Global Psoriatic Arthritis Treatment Market, By Route of Administration, 2017 – 2028, (US$ Mn)
o Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 – 2028
Segment Trends
o Topical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
o Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
o Injectable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
9. Global Psoriatic Arthritis Treatment Market, By Distribution Channel, 2017 – 2028, (US$ Mn)
o Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 – 2028
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
10. Global Psoriatic Arthritis Treatment Market, By Region, 2017 – 2028, (US$ Mn)
o Introduction
Market Share Analysis, By Region, 2021 and 2028 (%)
Y-o-Y Growth Analysis, For Regions, 2018–2028
o North America
Market Size and Forecast, By Drug Class, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Disease Type, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
U.S.
Canada
o Latin America
Market Size and Forecast, By Drug Class, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Disease Type, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Market Size and Forecast, By Drug Class, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Disease Type, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
Market Size and Forecast, By Drug Class, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Disease Type, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
Market Size and Forecast, By Drug Class, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Disease Type, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
GCC
Israel
Rest of Middle East
o Africa
Market Size and Forecast, By Drug Class, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Disease Type, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
Market Size and Forecast, By Country/Region, 2017 – 2028, (US$ Mn)
South Africa
Central Africa
North Africa
11. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
AbbVie Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Otsuka Pharmaceutical Co., Ltd.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Amgen Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Sanofi S.A.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Johnson & Johnson Services, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Novartis International AG
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
AstraZeneca
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Bausch Health Companies Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Janssen Biotech, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Bristol-Myers Squibb Company
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Eli Lilly and Company
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Pfizer, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
UCB S.A.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Sun Pharma Global FZE
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
AltruBio
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Merck & Co Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Celgene Corporation
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
o Analyst Views
12. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 40 market data tables and 32 figures on "Psoriatic Arthritis Treatment Market” - Global forecast to 2028

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings